MoonLake Immunotherapeutics

MLTX ·Healthcare, Drug Manufacturers - General, Switzerland
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 18, 2026
4 Jun 18, 2026
4 Jun 18, 2026
4 Jun 18, 2026
4 Jun 17, 2026
144 Jun 15, 2026
8-K Jun 9, 2026 CURRENT REPORT
8-K Jun 1, 2026 CURRENT REPORT
SCHEDULE 13G/A May 15, 2026
4 May 13, 2026
10-Q May 11, 2026 10-Q
8-K May 11, 2026 8-K
ARS Apr 21, 2026 ARS
DEFA14A Apr 21, 2026 DEFA14A
DEF 14A Apr 21, 2026 DEF 14A
4 Apr 16, 2026
4 Apr 14, 2026
4 Apr 10, 2026
144 Apr 10, 2026
144 Apr 9, 2026
4 Apr 2, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Apr 2, 2026
144 Mar 31, 2026
10-K Feb 25, 2026 10-K
8-K Feb 23, 2026 CURRENT REPORT
← Newer Page 2 of 14 · 329 filings Older →